参考文献/References:
[1]Stacy M, Galbreath A. Optimizing longterm therapy for Parkinson disease: levodopa, dopamine agonists, and treatmentassociated dyskinesia[J]. Clin Neuropharmacol, 2008, 31(1):51
[2]陈晓宇,陈晓蓉,李俊,等.帕金森病大鼠中脑腹侧被盖区多巴胺能神经元的改变[J]. 郑州大学学报:医学版, 2005,40(6):1 064
[3]赵荷剑, 柴立辉, 吴素霞, 等. 白细胞介素6与脑源性神经营养因子对大鼠神经前体细胞向多巴胺神经元分化的诱导作用[J]. 郑州大学学报:医学版,2009,44(1):93
[4]LeWitt PA. A perspective on adjunctive therapy for Parkinson disease with monoamine oxidaseB inhibition[J]. Clin Neuropharmacol, 2007, 30(5):305
[5]Yang HQ, Ba MW, Ren RJ, et al. Mitogen activated protein kinase and protein kinase C mediated promotion of sAPPα secretion by deprenyl[J]. Neurochem Int, 2007, 50(1): 74
[6]Sharma R, McMillan CR, Niles LP. Neural stem cell transplantation and melatonin treatment in a 6hydroxydopamine model of Parkinson’s disease[J]. J Pineal Res, 2007, 43(3):245
[7]Zbarsky V, Datla KP, Parkar S, et al. Neuroprotective properties of the natural phenolic antioxidants curcumin and naringenin but not quercetin and fisetin in a 6OHDA model of Parkinson’s disease[J]. Free Radic Res, 2005, 39(10):1 119
[8]Weng Z, Signore AP, Gao Y, et al. Leptin protects against 6hydroxydopamineinduced dopaminergic cell death via mitogenactivated protein kinase signaling[J]. J Biol Chem, 2007, 282(47):34 479
[9]Li Y, Wang B, Zhou C, et al. Matrine induces apoptosis in angiotensin IIstimulated hyperplasia of cardiac fibroblasts: effects on Bcl2/Bax expression and Caspase3 activation[J]. Basic Clin Pharmacol Toxicol, 2007,101(1):1
[10]Zeevalk GD, Manzino L, Sonsalla PK, et al. Characterization of intracellular elevation of glutathione (GSH) with glutathione monoethyl ester and GSH in brain and neuronal cultures: relevance to Parkinson’s disease[J]. Exp Neurol, 2007, 203(2):512
相似文献/References:
[1]赵莘瑜,许予明#,王海珍,等.非痴呆帕金森病患者轻度认知障碍与发病年龄和疾病阶段的关系[J].郑州大学学报(医学版),2010,(01):84.
ZHAO Xinyu,XU Yuming,WANG Haizhen,et al.Relationship of mild cognitive impairment and different age and stage of illness in nondemented Parkinson’s disease patients[J].JOURNAL OF ZHENGZHOU UNIVERSITY(MEDICAL SCIENCES),2010,(05):84.
[2]朱红灿)△,卢欣),赵鹏),等.促红细胞生成素对体外培养的SD大鼠多巴胺能神经元细胞活力的影响*[J].郑州大学学报(医学版),2009,(06):1185.
ZHU Hongcan),LU Xin),ZHAO Peng),et al.Effects of erythropoietin on viability of dopaminergic neurons of SD rats in vitro[J].JOURNAL OF ZHENGZHOU UNIVERSITY(MEDICAL SCIENCES),2009,(05):1185.
[3]张德智,赵青赞,任秀花,等.尼古丁对帕金森病大鼠多巴胺能神经元的保护作用[J].郑州大学学报(医学版),2010,(06):904.
[4]李治华,赵青赞,张华,等.尼古丁对脂多糖诱导的大鼠小胶质细胞激活和白细胞介素6表达的影响*[J].郑州大学学报(医学版),2011,(02):188.
LI Zhihua,ZHAO Qingzan,ZHANG Hua,et al.Effects of nicotine on LPSinduced microglia activation and cytokine IL6 expression in rats[J].JOURNAL OF ZHENGZHOU UNIVERSITY(MEDICAL SCIENCES),2011,(05):188.
[5]黄月),张善锋),许予明)#,等. 6羟基多巴胺诱导帕金森病大鼠相关蛋白及mRNA的表达[J].郑州大学学报(医学版),2011,(02):222.
HUAGN Yue,ZHANG Shanfeng,et al. Expression of related protein and mRNA in 6hydroxydopamineinduced Parkinson’s disease rats[J].JOURNAL OF ZHENGZHOU UNIVERSITY(MEDICAL SCIENCES),2011,(05):222.
[6]赵鹏),朱红灿)#,李玉生),等.帕金森病患者认知功能障碍的发生率及影响因素[J].郑州大学学报(医学版),2014,(06):869.
ZHAO Peng),ZHU Hongcan),LI Yusheng),et al.Incidence and related factors of Parkinson′s disease with cognitive dysfunction[J].JOURNAL OF ZHENGZHOU UNIVERSITY(MEDICAL SCIENCES),2014,(05):869.
[7]王淑秀)△,常海敏),朱丰霞),等.人参皂苷Rg1对帕金森病小鼠黑质多巴胺能神经元凋亡及EphB1、TH、PcJun蛋白表达的影响*[J].郑州大学学报(医学版),2015,(02):176.
WANG Shuxiu,CHANG Haimin,ZHU Fengxia,et al.Effects of ginsenoside Rg1 on apoptosis of dopamine neurons, expressions of EphB1,TH and PcJun in substantia nigra of mice with Parkinson′s disease[J].JOURNAL OF ZHENGZHOU UNIVERSITY(MEDICAL SCIENCES),2015,(05):176.